TD Cowen Reiterates Buy Rating on Novo Nordisk (NVO); Stock Named Best Idea 2025
Tweet Send to a Friend
TD Cowen analyst Michael Nedelcovych reiterated a Buy rating and $155.00 price target on Novo Nordisk (NYSE: NVO). The stock ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
